Baker Bros Advisors, renowned for their biotech expertise, increased their stake in Bicycle Therapeutics $BCYC from 19.76% to 22.90%, as disclosed in a 13D filing.
Thilo Schroeder, director of Revolution Medicines $RVMD and managing member of Nextech Invest, made waves with a $60 million insider buy, acquiring 1.3 million shares.
The most notable insider transaction today is revealed in a Form 4 filing by James Mikolaichik, the new CFO and Treasurer of United Parks & Resorts $PRKS.
Director Michael J. Angelakis, CEO of the investment company Atairos Group, and former CFO of Comcast, has acquired 3,465,000 shares of Clarivate Plc $CLVT.
The biggest insider move today comes from Paul J. Fribourg, a director at Estee Lauder Companies $EL, who purchased $10,045,534 worth of shares, as reported in a Form 4 filing.